The Nasal Dendritic Cell-Targeting Flt3 Ligand as a Safe Adjuvant Elicits Effective Protection Against Fatal Pneumococcal Pneumonia
Infection and Immunity - United States
doi 10.1128/iai.01360-10
Full Text
Open PDFAbstract
Available in full text
Date
May 2, 2011
Authors
Publisher
American Society for Microbiology